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Guest editorial
Hope for better days: 2 studies aiming to answer the remaining 
questions around dual mobility cups
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Readers of scientific papers are mostly interested in new find-
ings. By scanning the paper’s title, reading the summary and, 
when attracted by the conclusions, reading the full article, 
we hope to find new information that will help us to treat our 
patients better. In this issue of Acta Orthopaedica there are 
2 excellent papers, which I would recommend reading, but I 
need to warn readers beforehand. They do not contain new 
data yet, but are still worth the time investment required to 
read them (Van Beers et al. 2020, Wolf et al. 2020). 
Both articles concern the value of dual mobility cups 
(DMC). DMCs came onto the market to reduce the risk of 
dislocation after total hip arthroplasty. A spherical liner in a 
DMC encloses the metal femoral head and articulates with a 
thin metal shell, which is fixed to the acetabular bone. The 
first DMCs were developed in France, and publications from 
French colleagues suggested better range of motion and 
reduced dislocation rates. In many countries the enticing con-
cept of DMC was adopted, especially in patients with high 
risk of dislocation, and in many patients after revision hip 
surgery. Based on observational studies, the concept seems to 
work by reducing dislocation risks. But there are no well-pow-
ered randomized trials showing this clearly and there are still 
safety concerns because of the large polyethylene liner in a 
metal shell. Wear, aseptic loosening, periprosthetic infection, 
and intraprosthetic dislocation are all potential complications 
not yet studied in great detail. 
Due to the pioneering work of Scandinavian orthopedics, 
there are many well-run national implant registers worldwide, 
but unfortunately they cannot provide all the answers to the 
above questions. Implant registers report only dislocations 
that lead to revisions, but without surgery there is no informa-
tion on the actual dislocation rate. The only solution for the 
problem is a proper randomized controlled trial (RCT) and 
both papers give detailed descriptions of such study designs. 
Wolf et al. (2020) aim to perform a national (Swedish), 
multicenter, register-based RCT comparing a DMC with a 
standard cup in patients > 65 years with a non-pathological, 
displaced femoral neck fracture. Van Beers et al. (2020) plan 
to perform a similar national (Dutch) RCT but they compare 
a DMC with normal cup in all patients ≥ 70 years undergo-
ing elective primary hip arthroplasty. The power calculation of 
both studies leads to quite a high number of patients for each 
study—1,100 in the Dutch study and 1,600 in the Swedish 
study—and this explains why multiple centers are needed, to 
include sufficient patients. 
The papers illustrate excellently how much energy the prep-
aration of such studies requires from the researchers. How-
ever, not only the research plan but also the weakness of the 
studies are already openly and thoroughly considered in the 
Discussion section of the respective articles. This shows that 
even the best research plan is still a compromise and several 
good studies are necessary to reach the right conclusions.
A real challenge for all studies of this size is the follow-up. 
How to keep track of all the patients? For this reason, both 
studies are nested in the national arthroplasty registries (the 
Swedish Hip Arthroplasty Register and the Dutch Arthro-
plasty Register). After final study follow-up, all participants 
remain traceable in the arthroplasty registers for evaluation of 
long-term survival and mortality. Both studies will trace com-
plications leading to further surgery. The Swedish study will 
use the Swedish National Patient Register to detect all disloca-
tions, not only those leading to surgery. The researchers of the 
Swedish study have a clear advantage over the Dutch study, 
which intends to detect these dislocations with a questionnaire 
sent at 3-month, 1-year, and 2-year follow-up. Importantly, 
both studies also include health-economic evaluation of the 
use of dual mobility cups, which is relevant for society. Will 
the increased cost associated with DMC reduce total costs, 
including those caused by dislocations? 
The weakness of many orthopedic interventions is that their 
scientific foundation is weak and the complications and health-
care economic consequences are insufficiently studied. dual 
mobility cups are a clear example. They are promising but the 
proof is doubtful. Based on ambition and using the best sci-
entific tools as well as the excellent options from the national 
arthroplasty registers, the planned studies from Sweden and 
the Netherlands give us hope of a more knowledgeable future. 
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